TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,078,000 | +210.0% | 40,898 | +10.6% | 0.00% | – |
| Q1 2022 | $993,000 | -42.7% | 36,979 | +1.8% | 0.00% | -100.0% |
| Q4 2021 | $1,733,000 | -28.2% | 36,333 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,414,000 | +10.0% | 36,333 | +29.2% | 0.00% | 0.0% |
| Q2 2021 | $2,195,000 | -3.9% | 28,128 | +16.5% | 0.00% | 0.0% |
| Q1 2021 | $2,284,000 | -13.5% | 24,145 | +11.5% | 0.00% | 0.0% |
| Q4 2020 | $2,639,000 | +48.7% | 21,661 | +6.6% | 0.00% | 0.0% |
| Q3 2020 | $1,775,000 | +71.3% | 20,319 | +26.7% | 0.00% | 0.0% |
| Q2 2020 | $1,036,000 | +53.3% | 16,040 | +5.9% | 0.00% | – |
| Q1 2020 | $676,000 | +71.6% | 15,144 | +138.9% | 0.00% | – |
| Q4 2019 | $394,000 | +838.1% | 6,339 | +473.1% | 0.00% | – |
| Q3 2019 | $42,000 | -6.7% | 1,106 | 0.0% | 0.00% | – |
| Q2 2019 | $45,000 | – | 1,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |